News & Updates
Showing Pharmacy articles
Showing
Seladelpar delivers improvements in cholestatic biomarkers, pruritus in PBC patients
Treatment with seladelpar for up to 2 years improves cholestatic biomarkers and pruritus in patients with primary biliary cholangitis (PBC), with no serious safety concerns noted with long-term use, as shown by interim results of the ASSURE study.
Seladelpar delivers improvements in cholestatic biomarkers, pruritus in PBC patients
9 hours ago
Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
The extended-release combination of naltrexone and bupropion (NB-ER) may be used as safe and effective treatment for weight reduction among individuals with overweight/obesity and mild to moderate symptoms of depression, suggests a study.
Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
a day ago
Enzalutamide plus leuprolide delays metastasis, progression in prostate cancer
Prostate cancer patients treated with enzalutamide plus leuprolide have a higher probability of remaining free of distant metastasis, castration resistance, symptomatic progression, and first symptomatic skeletal event (SSE) at 5 years than those treated with leuprolide alone, as shown by the results of the EMBARK study.
